NewEdge Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.74K | Sell |
196
-1,425
| -88% | -$56.3K | ﹤0.01% | 3280 |
|
|
2025
Q1 | $48.9K | Sell |
1,621
-199
| -11% | -$6K | ﹤0.01% | 2566 |
|
|
2024
Q4 | $63.6K | Hold |
1,820
| – | – | ﹤0.01% | 2433 |
|
|
2024
Q3 | $72.9K | Sell |
1,820
-330
| -15% | -$13.2K | ﹤0.01% | 2303 |
|
|
2024
Q2 | $102K | Buy |
2,150
+125
| +6% | +$5.96K | ﹤0.01% | 2112 |
|
|
2024
Q1 | $87.8K | Sell |
2,025
-63
| -3% | -$2.73K | ﹤0.01% | 2102 |
|
|
2023
Q4 | $106K | Buy |
2,088
+974
| +87% | +$49.3K | ﹤0.01% | 1933 |
|
|
2023
Q3 | $50.5K | Buy |
1,114
+1,093
| +5,205% | +$49.6K | ﹤0.01% | 2094 |
|
|
2023
Q2 | $861 | Buy |
21
+13
| +163% | +$533 | ﹤0.01% | 3268 |
|
|
2023
Q1 | $286 | Sell |
8
-1,309
| -99% | -$46.8K | ﹤0.01% | 3289 |
|
|
2022
Q4 | $49.4K | Buy |
+1,317
| New | +$49.4K | ﹤0.01% | 1720 |
|
|
2017
Q3 | – | Sell |
-195
| Closed | -$10K | – | 722 |
|
|
2017
Q2 | $10K | Buy |
+195
| New | +$10K | ﹤0.01% | 957 |
|